Samotolisib
8-[5-(2-hydroxypropan-2-yl)-3-pyridinyl]-1-[(2S)-2-methoxypropyl]-3-methylimidazo[4,5-c]quinolin-2-one
Molecular Identity
Samotolisib
8-[5-(2-hydroxypropan-2-yl)-3-pyridinyl]-1-[(2S)-2-methoxypropyl]-3-methylimidazo[4,5-c]quinolin-2-one
PubChem CID: 57519748
2D Structure
Properties
C23H26N4O3
Molecular Formula
406.50
Molecular Weight
g/mol
406.2005
Exact Mass
Da
1.7
XLogP
Drug-like (Lipinski: < 5)
78.8
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
5
H-Bond Acceptors
630
Complexity
SMILES
Canonical SMILES
SMILES: CC(CN1C2=C3C=C(C=CC3=NC=C2N(C1=O)C)C4=CC(=CN=C4)C(C)(C)O)OCIsomeric SMILES
SMILES: C[C@@H](CN1C2=C3C=C(C=CC3=NC=C2N(C1=O)C)C4=CC(=CN=C4)C(C)(C)O)OCSynonyms(20)
Samotolisib1386874-06-1LY3023414LY-30234148-[5-(2-hydroxypropan-2-yl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methylimidazo[4,5-c]quinolin-2-oneLY 3023414C88817F47Y2H-Imidazo[4,5-c]quinolin-2-one, 1,3-dihydro-8-[5-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(2S)-2-methoxypropyl]-3-methyl-WHO 108892H-Imidazo(4,5-C)quinolin-2-one, 1,3-dihydro-8-(5-(1-hydroxy-1-methylethyl)-3-pyridinyl)-1-((2S)-2-methoxypropyl)-3-methyl-PI3K/MTOR INHIBITOR LY30234148-(5-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((2S)-2-methoxypropyl)-3-methylimidazo(4,5-c)quinolin-2-oneRefChem:1811058-(5-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((2S)-2-methoxypropyl)-3-methyl-1H,2H,3H-imidazo(4,5-c)quinolin-2-oneGTPL8918
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Samotolisib
Loading drug network...